{"id":125733,"date":"2022-05-20T12:55:59","date_gmt":"2022-05-20T12:55:59","guid":{"rendered":"https:\/\/ccs.ca\/?page_id=125733"},"modified":"2024-05-14T11:48:19","modified_gmt":"2024-05-14T15:48:19","slug":"2021-cardiovasculaire","status":"publish","type":"page","link":"https:\/\/ccs.ca\/fr\/2021-cardiovasculaire\/","title":{"rendered":"R\u00e9cipiendaires de la Bourse de recherche cardiovasculaire SCC-Bayer"},"content":{"rendered":"\n
<\/div>\n\n\n\n
2022<\/mark><\/h3>\n\n\n\n
Chercheurs principaux<\/th>
Titres des propositions<\/th>
Montants des bourses<\/th><\/tr><\/thead>
Ping Yu Xiong<\/strong> <\/td>
Investigating the Metabolomic Profile of Transplanted Heart with and without Pathological Signs of Rejection<\/td>
20 000 $<\/td><\/tr>
Kevin J. Um<\/strong> <\/td>
DiastologY-Guided MaNAgement of DecoMpensated Heart Failure \u2013 A Pilot RandomIzed, Controlled Trial (DYNAMIC)<\/td>
15 000 $ + 5 000 $ de prime de pr\u00e9sentation<\/td><\/tr>
Kevin R. An<\/strong> <\/td>
Long-term Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Women with Severe Coronary Artery Disease<\/td>
Subclinical Valve Thrombosis in Patients with Surgical Bioprosthetic Valve Replacements: An Imaging Pilot Substudy of the DANCE Trial<\/td>
20 000 $ + 5 000 $ de prime de pr\u00e9sentation<\/td><\/tr>
Haya Aziz<\/strong> <\/td>
Sex-related Differences in Biomarkers in Patients with Diabetes Mellitus Post Myocardial Infarction-II<\/td>
15 000 $<\/td><\/tr>
Spencer Lalonde<\/strong> <\/td>
Medication Optimization in the Heart Failure Clinic and the Impact on Left Ventricular Ejection Fraction: An Analysis of Recently Diagnosed Heart Failure Patients Followed at a Tertiary Centre<\/td>
Rivaroxaban with Aspirin in Type 2 Myocardial Infarctions: A Feasibility, Open-label, Randomized Controlled Trial<\/td>
20 000 $<\/td><\/tr>
Anna Zavodni<\/strong> <\/td>
A Novel Method of Hemolysis and Thrombosis Detection Utilizing Surface-Enhanced Raman Spectroscopy<\/td>
15 000 $<\/td><\/tr>
Maxime Robert-Halabi<\/strong> <\/td>
Optimal Utilization of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease<\/td>
10 000 $ + 5 000 $ de prime de pr\u00e9sentation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
2019<\/mark><\/h3>\n\n\n\n
Chercheurs principaux<\/th>
Titres des propositions<\/th>
Montants des bourses<\/th><\/tr><\/thead>
Pietro Di Santo<\/strong><\/td>
Direct Oral Anticoagulation Post-Transradial Access for the Prevention of Radial Artery Occlusion<\/td>
20 000 $<\/td><\/tr>
Pishoy Gouda<\/strong><\/td>
An Externally Validated Prediction Tool for Peripheral Arterial Disease in Patient with Documented Coronary Artery Disease<\/td>
15 000 $<\/td><\/tr>
Alice Chang<\/strong><\/td>
Beyond Atrial Fibrillation: Using Artificial Intelligence, Big Data and Imaging to Improve Stroke Risk Assessment and Management<\/td>
10 000 $ + 5 000 $ de prime de pr\u00e9sentation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
2018<\/mark><\/h3>\n\n\n\n
Chercheurs principaux<\/th>
Titres des propositions<\/th>
Montants des bourses<\/th><\/tr><\/thead>
Ali Alsagheir<\/strong><\/td>
Low INR to Minimize Bleeding with Mechanical Valves Trial (LIMIT) Pilot<\/td>
20 000 $<\/td><\/tr>
Jari M. Tuomi<\/strong><\/td>
Ibrutnib, Dose Dependently, Promotes Atrial Fibrillation in Mice by Depressing Cardiac Conduction<\/td>
15 000 $ + 5 000 $ de prime de pr\u00e9sentation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
2017<\/mark><\/h3>\n\n\n\n
Chercheurs principaux<\/th>
Titres des propositions<\/th>
Montants des bourses<\/th><\/tr><\/thead>
Thomas M. Roston<\/strong><\/td>
Cardiac RyAnodinereceptor Variants in Early-onset Atrial Fibrillation: The CRAVE-AF Study<\/td>
20 000 $ + 5 000 $ de prime de pr\u00e9sentation<\/td><\/tr>
Michael Chiu<\/strong><\/td>
Heat Shock Protein 27: A Potential Biomarker for Atrial Fibrillation<\/td>
12 500 $<\/td><\/tr>
Amine Mazine<\/strong><\/td>
A Pilot Echocardiographic and CT Imaging Study to Evaluate Subclinical Leaflet Thrombosis Following Surgical Bioprosthetic Aortic Valve Replacement<\/td>
Atrial Fibrillation Occurring Transiently with Stress (AFOTS) Understanding the Risks of Subsequent AF and Stroke<\/td>
20 000 $ + 5 000 $ de prime de pr\u00e9sentation<\/td><\/tr>
Saman Rezazadeh<\/strong><\/td>
Automated Reminder to Initiate Oral Anticoagulation in Patients with Atrial Fibrillation\/Atrial Flutter Discharged Directly From the Emergency Department: REMINDER STUDY<\/td>
12 500 $<\/td><\/tr>
Hadi Toeg<\/strong><\/td>
Hybrid Coronary Revascularization in Diabetics (HYCARDS) Randomized<\/td>
2022 Chercheurs principaux Titres des propositions Montants des bourses Ping Yu Xiong Investigating the Metabolomic Profile of Transplanted Heart with and without Pathological Signs of Rejection 20 000 $ Kevin J. Um DiastologY-Guided MaNAgement of DecoMpensated Heart Failure \u2013 A Pilot RandomIzed, Controlled Trial (DYNAMIC) 15 000 $ + 5 000 $ de prime de pr\u00e9sentation Kevin […]<\/p>\n","protected":false},"author":7813,"featured_media":0,"parent":0,"menu_order":93,"comment_status":"closed","ping_status":"closed","template":"page-no-sidebar.php","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":""},"wf_page_folders":[181],"acf":[],"yoast_head":"\n
R\u00e9cipiendaires de la Bourse de recherche cardiovasculaire SCC-Bayer - Soci\u00e9t\u00e9 cardiovasculaire du Canada<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n